Pharmaceutical Technology - Pharmaceutical Manufacturing & Development News & Research for Scientists

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Pharma Investments Reflect Key Industry Trends
Shrinking facility size, growth of biologics, and emerging market demand influence pharma investments.
Implementing Supply-Chain Security
The US federal Drug Quality and Security Act (DQSA) and more specifically the Drug Supply Chain Security Act (DSCSA), referring to Title II of the law, requires phase-in of requirements to prevent counterfeiting. An expert discusses how companies should be preparing to meet the requirements of the DSCSA.
Comparing Manufacturing Process Options
A techno-economic profiling method supports pharmaceutical process development by helping identify the best manufacturing approach.
Bioavailability Enhancement with Lipid-Based Drug-Delivery Systems
Experts from Capsugel and Catalent discuss the rationale of using lipid-based formulations to improve the oral bioavailability of poorly soluble drugs.
Positive Outlook for Outsourcing
Contract services ride high as funding floods bio/pharma.
Shifting Gears in Drug Development Outsourcing Responsibilities
For a bio/pharma industry in flux, contract services are playing a greater—and more diverse—role in drug development.
PharmTech eBook Series
Bioprocessing and Sterile Manufacturing
Review emerging trends in the development and manufacturing of parenteral and biologic drugs, including continuous manufacturing, monitoring, sterilization procedures, modular manufacturing, and single-use technologies.
Solid Dosage and Excipients
Review emerging trends in the formulation and manufacture of solid dosage drugs, as well as the role of excipients in enhancing the functionality of these drug forms.

Expert Interviews, Industry Trends, and more

USP Supply Chain Safety Videos
Peer-Reviewed Articles
Comparing Manufacturing Process Options
Cleanability of Pharmaceutical Soils from Different Materials of Construction
Achieving Zero-Order Release Kinetics Using Multi-Step Diffusion-Based Drug Delivery
Through-Vial Impedance Spectroscopy: A New In-Line Process Analytical Technology for Freeze Drying
A New Approach to Forced Degradation Studies Using Anhydrous Conditions
sponsored by
From Generics to Supergenerics
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Twitter LinkedIn
Industry Leaders: Q+A
Q&A with Paul Nelles, Vetter Development Service
Paul Nelles of Vetter Development Service discusses prefilled syringes.
Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results

PharmTech Europe 25th Anniversary
Tracking the Pulse of the Pharmaceutical Industry
Pharmaceutical Technology Europe marks its 25th anniversary.
Standards & Regulations
Europe Leads Generic-Drugs Assessment Project
The European system for assessing drugs will be used as a model internationally.
Device that Detects Counterfeit Drugs Gets Grant
PharmaChk, a portable device being developed to detect substandard medicines, receives $2-million grant.
Industry Takes Steps to Prevent Counterfeit Drugs
The fight against counterfeit drugs is an international effort, as exemplified by the ?Fight the Fakes? campaign.
Implementing Supply-Chain Security
The US federal Drug Quality and Security Act (DQSA) and more specifically the Drug Supply Chain Security Act (DSCSA), referring to Title II of the law, requires phase-in of requirements to prevent counterfeiting. An expert discusses how companies should be preparing to meet the requirements of the DSCSA.
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
Click here